250 related articles for article (PubMed ID: 16417651)
21. Case-control study of increased mammographic breast density response to hormone replacement therapy.
Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
[TBL] [Abstract][Full Text] [Related]
22. [Utilization of hormone replacement therapy in Spain: Trends in the period 2000-2014].
Baladé Martínez L; Montero Corominas D; Macías Saint-Gerons D
Med Clin (Barc); 2016 Oct; 147(7):287-92. PubMed ID: 27423654
[TBL] [Abstract][Full Text] [Related]
23. Influence of menopausal status and use of hormone replacement therapy on radiation dose from mammography in routine breast screening.
Whitaker CJ; Kelly CM; Faulkner K; Stamp EC
Br J Radiol; 2006 Jul; 79(943):597-602. PubMed ID: 16823065
[TBL] [Abstract][Full Text] [Related]
24. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
[TBL] [Abstract][Full Text] [Related]
26. Postmenopausal hormone therapy and mammographic breast density.
Marchesoni D; Driul L; Ianni A; Fabiani G; Della Martina M; Zuiani C; Bazzocchi M
Maturitas; 2006 Jan; 53(1):59-64. PubMed ID: 15939560
[TBL] [Abstract][Full Text] [Related]
27. Effects of hormone replacement therapy on mammographic findings.
Bülbül NH; Ozden S; Dayicioglu V
Arch Gynecol Obstet; 2003 Apr; 268(1):5-8. PubMed ID: 12673467
[TBL] [Abstract][Full Text] [Related]
28. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.
Wu MH; Pan HA; Wang ST; Hsu CC; Chang FM; Huang KE
Climacteric; 2001 Dec; 4(4):314-9. PubMed ID: 11770188
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
30. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
Collaborative Group on Hormonal Factors in Breast Cancer
Lancet; 2019 Sep; 394(10204):1159-1168. PubMed ID: 31474332
[TBL] [Abstract][Full Text] [Related]
31. Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
Reeves GK; Beral V; Green J; Gathani T; Bull D;
Lancet Oncol; 2006 Nov; 7(11):910-8. PubMed ID: 17081916
[TBL] [Abstract][Full Text] [Related]
32. Hormone replacement therapy use and variations in the risk of breast cancer.
Opatrny L; Dell'Aniello S; Assouline S; Suissa S
BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
[TBL] [Abstract][Full Text] [Related]
33. [Impact of menopause hormone replacement therapy on screening mammography reading].
Meye NE; Schaffer P; Hédelin G; Guldenfels C; Gairard B
J Radiol; 2001 Jun; 82(6 Pt 1):653-9. PubMed ID: 11449167
[TBL] [Abstract][Full Text] [Related]
34. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
35. Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study.
Benson VS; Pirie K; Green J; Bull D; Casabonne D; Reeves GK; Beral V;
Int J Cancer; 2010 Oct; 127(7):1692-8. PubMed ID: 20091865
[TBL] [Abstract][Full Text] [Related]
36. Type of hormone therapy and risk of misclassification at mammography screening.
Njor SH; Hallas J; Schwartz W; Lynge E; Pedersen AT
Menopause; 2011 Feb; 18(2):171-7. PubMed ID: 20729766
[TBL] [Abstract][Full Text] [Related]
37. Use of HRT and the subsequent risk of cancer.
Beral V; Banks E; Reeves G; Appleby P
J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
[TBL] [Abstract][Full Text] [Related]
38. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
39. Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study.
Banks E; Reeves G; Beral V; Bull D; Crossley B; Simmonds M; Hilton E; Bailey S; Barrett N; Briers P; English R; Jackson A; Kutt E; Lavelle J; Rockall L; Wallis MG; Wilson M; Patnick J
BMJ; 2004 Aug; 329(7464):477. PubMed ID: 15331472
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer in women who undergo screening mammography: relationship of hormone replacement therapy to stage and detection method.
Roubidoux MA; Wilson TE; Orange RJ; Fitzgerald JT; Helvie MA; Packer SA
Radiology; 1998 Sep; 208(3):725-8. PubMed ID: 9722852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
